Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
OSE Immuno (OSE FP)
Watchlist
35
Analysis
Health Care
•
France
OSE Immunotherapeutics SA is a biotechnology company based in France, developing immunotherapy products against invasive/metastatic late-stage cancers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
OSE Immuno
•
03 Nov 2022 17:02
•
Issuer-paid
OSE Immunotherapeutics - OSE-127 Phase II study enrolment completed
OSE Immunotherapeutics (OSE) completed patient recruitment in its Phase IIa study (NCT04605978) investigating its monoclonal antibody therapy,...
Edison Investment Research
Follow
295 Views
Share
bullish
•
OSE Immuno
•
23 Sep 2022 23:02
•
Issuer-paid
OSE Immunotherapeutics - Tedopi remains focus in FY22
The pathway to regulatory approval for OSE’s neoepitope cancer vaccine, Tedopi, continues to be a key point of focus for the company. Following the...
Edison Investment Research
Follow
664 Views
Share
bullish
•
OSE Immuno
•
08 Jun 2022 22:28
•
Issuer-paid
OSE Immunotherapeutics - Tedopi clinical data in NSCLC and PDAC
OSE Immunotherapeutics has highlighted recent clinical data for its multiple neoepitope cancer vaccine, Tedopi (OSE2101) at the American Society of...
Edison Investment Research
Follow
663 Views
Share
bullish
•
OSE Immuno
•
19 May 2022 19:57
•
Issuer-paid
OSE Immunotherapeutics - First patient dosed with FR104/VEL-101
OSE Immunotherapeutics has announced that the first participant in a Phase I study has been dosed with the company’s CD28-targeting antibody...
Edison Investment Research
Follow
433 Views
Share
bullish
•
OSE Immuno
•
03 May 2022 19:00
•
Issuer-paid
OSE Immunotherapeutics - Steady progress on all fronts
OSE Immunotherapeutics (OSE) and its three pharma partners have made progress with all key clinical and preclinical assets. The final analysis of...
Edison Investment Research
Follow
2 Views
Share
First
Previous
3
4
5
6
7
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x